The company has been asked to submit the safety data of M1 adjuvant — the patented technology of Novavax made to enhance the immune response — along with published literature.
Speaking at the Global Technology Summit 2020 organised by Carnegie India, Poonawalla said the government can intervene and protect vaccine manufacturers from 'frivolous claims'.
The applications of Bharat Biotech and Serum Institute of India are under consideration, while that of the Indian arm of Pfizer has not yet been taken up.
3 firms have applied for emergency use approval, but no clarity yet on if people will get to choose a vaccine, or what the state’s role in procurement will be.
The recommendations on granting of authorisation will be made on three parameters — safety, quality and efficacy. The Drug Controller General of India will take the final decision.
According to the ICMR, Serum Institute of India has already manufactured 40 million doses of the vaccine under the at-risk manufacturing and stockpiling license obtained from DCGI.
ICMR chief Dr Balram Bhargava says the idea is to reach a ‘critical mass’, which refers to a point when there are enough people who have been vaccinated to break transmission chain.
Participant in Covid vaccine trial sent legal notice to Serum Institute, claiming neurological & psychological symptoms, seeking Rs 5 crore in compensation.
Poonawalla, CEO of the Serum Institute of India, disclosed that the pharma giant will apply for emergency authorisation of the Covid-19 vaccine in the next 2 weeks.
India’s defence sector is trying to penetrate the African market. But with China already extending significant influence, India must now play catch-up.
Discussion about outcome of Lok Sabha polls continues to boil in cauldron of expectations only from BJP. Now reverse this equation, what if we asked about the performance of the 'loser'?
Seems that someone wants to get vaccine knowhow for free.
Is it? But there wd be protocols for confidentiality of data, no?